Evidence map›Paper›PMID 34066026›Full record

ArticleBiomolecules2021

Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss.

Ronald Biemann, Enrico Buß, Dirk Benndorf, Theresa Lehmann, Kay Schallert, Sebastian Püttker, Udo Reichl, Berend Isermann, Jochen G Schneider, Gunter Saake and 1 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ronald BiemannInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Leipzig University, Paul-List-Str. 13/15, 04103 Leipzig, Germany.
Enrico BußBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Dirk BenndorfBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.ORCID 0000-0003-4021-8525
Theresa LehmannBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Kay SchallertBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Sebastian PüttkerBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Udo ReichlBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Berend IsermannInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Leipzig University, Paul-List-Str. 13/15, 04103 Leipzig, Germany.
Jochen G SchneiderLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 6, Avenue du Swing, L-4367 Belvaux, Luxembourg.ORCID 0000-0003-2139-0602
Gunter SaakeDatabase and Software Engineering Group, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
Robert HeyerBioprocess Engineering, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.ORCID 0000-0001-7840-8899
Otto-von-Guericke-Universität Magdeburg · DELeipzig University · DEAnhalt University of Applied Sciences · DEMax Planck Institute for Dynamics of Complex Technical Systems · DEUniversity of Luxembourg · LU

Funding

German Federal Ministry of Education and Research 031L0103German Research Society BI 2051/1-1German Research Society HE 8077/1-1German Research Society IS 67/11-1Stiftung Pathobiochemie und Molekulare Diagnostik
6 · The paper itself

Abstract

Gut microbiota-mediated inflammation promotes obesity-associated low-grade inflammation, which represents a hallmark of metabolic syndrome. To investigate if lifestyle-induced weight loss (WL) may modulate the gut microbiome composition and its interaction with the host on a functional level, we analyzed the fecal metaproteome of 33 individuals with metabolic syndrome in a longitudinal study before and after lifestyle-induced WL in a well-defined cohort. The 6-month WL intervention resulted in reduced BMI (-13.7%), improved insulin sensitivity (HOMA-IR, -46.1%), and reduced levels of circulating hsCRP (-39.9%), indicating metabolic syndrome reversal. The metaprotein spectra revealed a decrease of human proteins associated with gut inflammation. Taxonomic analysis revealed only minor changes in the bacterial composition with an increase of the families Desulfovibrionaceae, Leptospiraceae, Syntrophomonadaceae, Thermotogaceae and Verrucomicrobiaceae. Yet we detected an increased abundance of microbial metaprotein spectra that suggest an enhanced hydrolysis of complex carbohydrates. Hence, lifestyle-induced WL was associated with reduced gut inflammation and functional changes of human and microbial enzymes for carbohydrate hydrolysis while the taxonomic composition of the gut microbiome remained almost stable. The metaproteomics workflow has proven to be a suitable method for monitoring inflammatory changes in the fecal metaproteome.

Indexed as

Gastrointestinal MicrobiomeLife StyleBacteriaFecesHumansInflammationInsulin ResistanceLongitudinal StudiesMaleMetabolic SyndromeMiddle AgedObesityProteomeWeight LossProteomefecal samplesgut inflammationmetabolic syndromemetaproteomicsmicrobiomeobesityweight loss

Identifiers

PMID34066026
PMCPMC8150863
OpenAlexW3159991572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.